Basic Information
Basic information for AC068587.4-201-16aa
Peptide Name AC068587.4-201-16aa
Genome Position chr8:12470484-12470531[-]
Species Human
Peptide Sequence MLFICSFAPATLPQPL
Peptide Length 16
Unique No (AC087203.3-201-16aa,AC092111.1-201-16aa-3,AC105233.5-202-16aa,FAM66D-202-16aa-2,FAM66D-204-16aa-2,FAM66D-205-16aa-2,FAM66D-206-16aa-2,FAM66D-210-16aa-2,FAM66D-211-16aa-2,FAM66D-212-16aa-2)
Grand Average of Hydropathicity 1.2312
Relative Molecular Mass 2019.4
Experimental Evidences no
lncRNA ID/Name ENSG00000283674;AC068587.4
Transcript ID/Name ENST00000641618;AC068587.4-201
Transcript Length 4514
Coding Ability 0.4001
DNA Sequence Corresponding to Peptide ATGTTGTTCATTTGTAGCTTTGCCCCAGCCACTTTGCCCCAACCACTT
Experimental Evidences
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :